Nabi(美国)

Nabi Biopharmaceuticals

美国NabiBiopharmaceuticals www.nabi.com 美国Nabi生物制药公司研发的一种用于治疗尼古丁成瘾和预防复吸疫苗NieVax（尼古丁接合疫苗）获得FDA授予的快通道审批地位。该疫苗将在第二季度进入Ⅱ期概念验证临床试验阶段，包括300位患者，试验结果将于2007年下半年得出。在未来几年里，戒烟市场将发生明显变化。PentaStaph（五金黄色葡萄球菌疫苗）Nab iBiopharmaceuticalsisfocusedondevelopingaseriesoffirstandsecondgenerationproductsthataddressunmetmedicalneedsandofferopportunitiesinourcorebusinessareas:nicotineaddictionandgram-positivebacterialinfections.Drivenbyourclinicaldevelopmentprograms,wearefocusedonbuildingvalueandareseekingpartnersforourvaccineprograms:NicVAX®(NicotineConjugateVaccine)andPentaStaph™(StaphylococcalPolysaccharideConjugateandToxoidVaccine).OurheadquartersislocatedinRockville,MarylandalongwithourResearchandDevelopmentfacility.